| Literature DB >> 18380425 |
Kevin Tidgewell1, Chad E Groer, Wayne W Harding, Anthony Lozama, Matthew Schmidt, Alfred Marquam, Jessica Hiemstra, John S Partilla, Christina M Dersch, Richard B Rothman, Laura M Bohn, Thomas E Prisinzano.
Abstract
Salvinorin A is a psychoactive natural product that has been found to be a potent and selective kappa opioid receptor agonist in vitro and in vivo. The activity of salvinorin A is unusual compared to other opioids such as morphine in that it mediates potent kappa opioid receptor signaling yet leads to less receptor downregulation than observed with other kappa agonists. Our initial chemical modifications of salvinorin A have yielded one analogue, herkinorin ( 1c), with high affinity at the microOR. We recently reported that 1c does not promote the recruitment of beta-arrestin-2 to the microOR or receptor internalization. Here we describe three new derivatives of 1c ( 3c, 3f, and 3i) with similar properties and one, benzamide 7b, that promotes recruitment of beta-arrestin-2 to the microOR and receptor internalization. When the important role micro opioid receptor regulation plays in determining physiological responsiveness to opioid narcotics is considered, micro opioids derived from salvinorin A may offer a unique template for the development of functionally selective mu opioid receptor-ligands with the ability to produce analgesia while limiting adverse side effects.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18380425 PMCID: PMC2494883 DOI: 10.1021/jm701162g
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446